Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II.
Miriana d'AlessandroLaura BergantiniDalila CavallaroSara GangiPaolo CameliEdoardo Conticininull Siena Covid UnitBruno FredianiFrancesco DottaElena BargagliPublished in: International journal of environmental research and public health (2022)
In conclusion, our study demonstrated that CLEIA and FEIA methods for serum KL-6 detection are comparable and reliable. KL-6 was confirmed as an easily detectable and effective biomarker to identify severe COVID-19 patients.